Recommended Global Psychiatry Webinars & Conferences

Europe & UK

CLINICAL PSYCHOLOGISTS 2027, France Mental Health 2027, Italy Euro Dementia-2027, France Child Psychology 2027, Switzerland Euro Psychiatry 2027, France

Asia Pacific & Middle East

Canada

Annual Mental Health 2027, Canada

WORLD PSYCHIATRY 2027

Welcome to an Inspiring Journey in Psychiatry!

Dear Valued Participants,

It is our great pleasure to welcome you to the 8th Annual Congress on Psychiatry, taking place on March 25–26, 2027, in Paris, France.

Under the theme “Rethinking Psychiatry: Connecting Neuroscience, Innovation and Human Wellbeing,” this congress aims to bring together psychiatrists, neuroscientists, psychologists, researchers, healthcare professionals, and experts from around the world to exchange knowledge, explore emerging developments, and discuss innovative approaches to mental health and psychiatric care.

Join us for an enriching scientific gathering featuring insightful presentations, meaningful discussions, research advancements, and valuable networking opportunities. Your expertise and contributions will help inspire new perspectives and strengthen global collaboration in advancing psychiatric science and mental wellbeing.

We warmly welcome you to Paris and look forward to your active participation in making this congress a meaningful and memorable scientific experience.

An Overview of Our Scientific Gathering

The 8th Annual Congress on Psychiatry 2027, scheduled for March 25–26, 2027, in Paris, France, will bring together a diverse community of psychiatrists, neurologists, neuroscientists, psychologists, researchers, academicians, mental health specialists, and healthcare professionals from across the globe.

The conference aims to provide an international platform for sharing scientific knowledge, presenting research findings, discussing clinical experiences, and exploring the latest developments in psychiatric science and mental healthcare.

We invite you to:

Submit your abstract and share your latest findings in psychiatric research and clinical practice.
Register to participate in discussions shaping the future of mental healthcare.
Explore the call for abstracts and discover presentation opportunities across diverse psychiatric disciplines.
Download the conference brochure to review the scientific programme and participation details.
Meet fellow researchers, clinicians, and scientific committee members contributing to advances in psychiatry.
Participate in the poster competition and present your research to an international professional audience.

Let us work together to advance psychiatric knowledge, strengthen evidence-based care, encourage interdisciplinary research, and explore innovative approaches to improving mental wellbeing, psychiatric disorders across diverse populations.

Scope & Importance

The 8th Annual Congress on Psychiatry, taking place on March 25–26, 2027, in Paris, France, will bring together international specialists to explore emerging developments in psychiatric research, clinical mental healthcare, neuroscience, and psychological interventions. The congress aims to encourage scientific exchange, interdisciplinary collaboration, and new perspectives on understanding and addressing mental health challenges across diverse populations.

Who Should Attend?

Explore emerging developments in clinical psychiatry, neuroscience, psychiatric diagnosis, and evidence-based treatment approaches.
Share original research and clinical insights with international experts in mental health and behavioural science.
Discover evolving perspectives on psychiatric disorders, personalised care, digital psychiatry, and therapeutic innovation.
Build professional connections across universities, healthcare institutions, research centres, and mental health organisations.
Contribute to discussions advancing psychiatric knowledge, accessible mental healthcare, and improved patient outcomes worldwide.

Who Should Participate?

This congress welcomes professionals and emerging researchers working across the broad spectrum of psychiatry and mental health, including:

Psychiatrists and Clinical Psychologists
Psychotherapists and Mental Health Practitioners
Psychiatric Researchers and Neuroscientists
Psychiatric Nurses and Counsellors
Neurologists and Behavioural Scientists
Child and Adolescent Mental Health Specialists
Academicians, Students and Research Scholars
Addiction and Rehabilitation Specialists
Public Health Professionals and Mental Health Advocates
Digital Psychiatry Researchers and Healthcare Innovators

Join the World Psychiatry 2027 in Paris to exchange scientific perspectives, discover new research directions, and contribute to the continuing advancement of psychiatric care and global mental health.

Scientific Sessions & Emerging Topics

Track 1: Clinical Psychiatry & Contemporary Psychiatric Practice

Clinical psychiatry plays a vital role in identifying, diagnosing, and managing mental health disorders. Advances in neuroscience, psychological science, pharmacology, and clinical assessment are shaping modern psychiatric practices and personalized treatment approaches.

This track focuses on clinical assessment, diagnostic methods, treatment planning, integrated mental healthcare, and patient-centred psychiatry. It also explores complex psychiatric conditions, multidisciplinary care, and emerging innovations that improve the quality and continuity of psychiatric services.

Track 2: Depression, Anxiety & Mood Disorders

Depression and anxiety represent major areas of psychiatric research, while bipolar and related mood disorders present distinctive challenges involving mood instability, recurrence, cognition, functioning, and treatment response. Research continues to examine the biological, psychological, genetic, and environmental factors contributing to these conditions.

The track will address advances in recognition, assessment, treatment, prevention, and recovery across mood and anxiety disorders. Particular attention will be given to treatment-resistant depression, innovative pharmacological approaches, psychotherapy, digital interventions, biomarkers, relapse prevention, and personalized treatment strategies.

Track 3: Schizophrenia & Psychotic Disorders

Schizophrenia and psychotic disorders can affect perception, thinking, cognition, emotional expression, behavior, and social functioning. Understanding the biological and psychological processes associated with psychosis remains an important area of psychiatric research, particularly in relation to early recognition and long-term recovery.

Current research is increasingly focused on first-episode psychosis, early intervention, cognitive symptoms, negative symptoms, antipsychotic treatment, psychosocial rehabilitation, and functional recovery. This track welcomes clinical and translational work exploring improved approaches to diagnosis, treatment response, and long-term support.

Track 4: Child & Adolescent Psychiatry

Child and adolescent psychiatry addresses mental health during periods of rapid neurological, emotional, social, and psychological development. Experiences during these stages can influence education, relationships, family life, behavior, and later mental health. Early recognition of psychiatric and developmental difficulties can therefore be particularly important. Conditions such as ADHD, autism spectrum conditions, childhood anxiety, depression, behavioral disorders, eating disorders, and trauma-related difficulties require approaches adapted to developmental needs.

The track will explore the interaction between children, families, schools, communities, and healthcare services in promoting healthy psychological development.

Track 5: Geriatric Psychiatry & Mental Health in Later Life

Mental healthcare in later life involves the interaction of psychiatric symptoms with aging, neurological disorders, physical illness, medication use, social isolation, and changes in independence. Older adults may experience depression, anxiety, cognitive impairment, dementia, behavioral symptoms, sleep difficulties, and other conditions requiring coordinated care.

Geriatric psychiatry therefore extends beyond symptom management to include cognitive health, functional independence, caregiver support, quality of life, and healthy aging.

Track 6: Neuropsychiatry & Cognitive Disorders

Neuropsychiatry examines the relationship between brain disorders and changes in mood, behavior, cognition, and personality. Neurological conditions such as epilepsy, stroke, traumatic brain injury, and neurodegenerative disorders can produce psychiatric manifestations that require both neurological and psychiatric expertise.

Research in this area is helping clarify the relationship between brain function and psychiatric symptoms. The track will include neuropsychological assessment, cognitive disorders, behavioral neurology, rehabilitation, and multidisciplinary approaches to patients with complex neurological and psychiatric needs.

Track 7: Psychopharmacology & Psychiatric Drug Development
Psychopharmacology continues to develop as researchers investigate new molecular targets, mechanisms of action, treatment strategies, and approaches to improving therapeutic response. Established medications remain important in psychiatric practice, while research into novel compounds aims to address conditions in which current treatments have limitations.

This track will examine pharmacological advances across depression, psychosis, bipolar disorder, anxiety, addiction, and other psychiatric conditions. Topics may include drug discovery, pharmacodynamics, pharmacokinetics, adverse effects, treatment resistance, combination therapy, and emerging therapeutic targets.

Track 8: Psychotherapy & Psychological Interventions
Psychological therapies remain an important part of comprehensive psychiatric care. Different therapeutic approaches have been developed to address mood disorders, anxiety, trauma, personality disorders, addiction, interpersonal difficulties, and other mental health conditions.

Contemporary research is examining how psychotherapy can be adapted to individual needs, delivered through digital platforms, integrated with pharmacological treatment, and improved through better understanding of therapeutic processes.

Track 9: Addiction Psychiatry & Behavioral Addictions
Addiction psychiatry examines the relationship between substance use, reward mechanisms, emotional regulation, psychiatric comorbidity, and social environment. Substance-use disorders frequently occur alongside depression, anxiety, trauma, psychosis, and other mental health conditions, creating complex clinical challenges.

The field is also expanding beyond traditional substance dependence to include behavioral patterns involving gambling, gaming, internet use, and other potentially compulsive behaviors. Research addressing prevention, neurobiology, treatment, relapse, recovery, and integrated care will be discussed.

Track 10: Women's Mental Health & Reproductive Psychiatry
Mental health can be influenced by reproductive events and hormonal transitions throughout a woman's life. Pregnancy, childbirth, postpartum changes, fertility-related experiences, menstruation, and menopause may interact with mood, anxiety, sleep, cognition, and psychological well-being.

Reproductive psychiatry therefore requires consideration of both psychiatric symptoms and the biological and social context surrounding reproductive health.

Track 12: Suicide Prevention, Self-Harm & Crisis Psychiatry
Suicide prevention remains an important area of psychiatric practice and public Suicidal behaviour and self-harm are complex mental health concerns influenced by psychological, psychiatric, social, environmental, and personal factors. Conditions such as depression, anxiety, trauma, substance-use disorders, and social isolation may contribute to increased vulnerability and emotional distress.

This track focuses on suicide risk assessment, early identification, prevention strategies, crisis intervention, psychological support, and evidence-based treatment approaches. It also highlights community-based initiatives, patient support systems, and continuity of care to strengthen mental health awareness and improve prevention efforts.

Track 14: Eating Disorders & Nutritional Psychiatry
Eating disorders involve complex interactions between eating behaviours, body image, emotional well-being, biological processes, and social influences. Conditions such as anorexia nervosa, bulimia nervosa, and binge-eating disorder can significantly affect both psychological and physical health, requiring early diagnosis and multidisciplinary treatment approaches.

This track explores advances in the assessment, prevention, and treatment of eating disorders, including psychological interventions, nutritional rehabilitation, and behavioural therapies. It also highlights emerging research in nutritional psychiatry, focusing on the relationship between diet, metabolism, gut-brain interactions, cognitive function, mood regulation, and overall mental well-being.

Track 15: Sleep Psychiatry & Circadian Mental Health
Sleep is closely connected with emotional regulation, cognition, stress, and psychiatric well-being. Persistent sleep disruption may contribute to psychiatric symptoms, while depression, anxiety, bipolar disorder, trauma, and other conditions can substantially alter sleep patterns.

This track will explore the bidirectional relationship between sleep and mental health, including insomnia, circadian rhythm disturbances, sleep-related psychiatric symptoms, and behavioral approaches to improving sleep.

Track 16: Psychosomatic Medicine & Consultation-Liaison Psychiatry
Psychiatric symptoms and physical health are frequently interconnected. Psychological distress may influence physical symptoms, treatment adherence, health behaviors, and recovery, while chronic or serious medical conditions can have significant effects on emotional well-being.

Consultation-liaison psychiatry provides an important bridge between psychiatric expertise and other medical specialties. Explore psychosomatic medicine, medically associated psychiatric conditions, chronic pain, somatic symptoms, health anxiety, and integrated psychiatric care in medical settings.

Track 17: Artificial Intelligence & Data-Driven Psychiatry
Artificial intelligence is emerging as a significant area of psychiatric research. Machine learning and large-scale data analysis can help researchers examine patterns in symptoms, behavior, treatment response, language, and other measurable characteristics.

Potential applications include predictive modeling, digital biomarkers, clinical decision support, research analysis, and personalized approaches to mental healthcare. Also address responsible implementation, transparency, privacy, algorithmic bias, validation, and ethical questions surrounding AI in psychiatry.

Track 18: Future Frontiers & Emerging Innovations in Psychiatry
The future of psychiatry is being shaped by the convergence of neuroscience, genetics, pharmacology, psychology, digital technologies, artificial intelligence, and personalized medicine. These developments are creating new possibilities for understanding mental disorders and developing more individualized approaches to care.

Emerging research may transform how psychiatric conditions are detected, classified, treated, and monitored. At the same time, new technologies raise important questions about evidence, ethics, accessibility, privacy, and the role of human judgement in mental healthcare. Provide a forward-looking platform for innovative research, emerging technologies, experimental therapies, and ideas that may influence the next generation of psychiatric science.

Market Analysis Report: Psychiatry (2026–2030)

The global psychiatry and mental healthcare market is growing steadily due to increasing mental health awareness, rising psychiatric disorders, advancements in neuroscience, and demand for accessible treatment. The global telepsychiatry market is projected to reach USD 42.3 billion by 2030, with an estimated CAGR of 21.9%, while the digital mental health market is expected to reach USD 58.67 billion by 2030, growing at a CAGR of 16.3%.

Key Growth Drivers:

Rising cases of depression, anxiety, and other psychiatric disorders.
Increasing mental health awareness and healthcare investments.
Advancements in neuroscience and psychiatric treatments.
Growing adoption of telepsychiatry and digital healthcare.

Emerging Trends:

Artificial Intelligence in Psychiatric Diagnosis.
Precision Psychiatry and Personalized Treatment.
Digital Mental Health and Telemedicine.
Neuroimaging and Brain Mapping.
Innovative Psychopharmacology and Drug Development.

Future Scope:

The psychiatry sector offers promising opportunities through AI-assisted diagnosis, personalized medicine, digital therapeutics, and advanced neuroscience research. Increasing international collaboration, clinical innovation, and investment in mental healthcare are expected to strengthen the industry through 2030.

Looking Back at Psychiatry 2026

The 7th Annual Congress on Psychiatry 2026, held on March 9–10, 2026, in Singapore City, Singapore, marked another step in bringing the global psychiatry community together. The conference aimed to provide a platform for psychiatrists, researchers, neuroscientists, psychologists, and healthcare professionals to exchange scientific knowledge, share research perspectives, and explore developments in psychiatric care.

The scientific gathering highlighted the importance of interdisciplinary collaboration, professional networking, and knowledge exchange in addressing evolving challenges in mental health and psychiatry.

We are pleased to continue this journey with the 8th Annual Congress on Psychiatry 2027, building on the spirit of scientific discussion, research advancement, and international collaboration.

To Collaborate Scientific Professionals around the World

Conference Date March 25-26, 2027

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Journal of Psychology & Psychotherapy Journal of Psychiatry Journal of Depression and Anxiety

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Psychiatry

March 25-26, 2027 Paris, France

Rethinking Psychiatry: Connecting Neuroscience, Innovation and Human Wellbeing

Conference Series Conferences gaining more Readers and Visitors